Testosterone Replacement Therapy
Showing 1 - 25 of >10,000
Hypogonadism, Malignant Urinary System Tumor, Urinary System Disorder Trial in Atlanta (other, procedure, drug)
Recruiting
- Hypogonadism
- +3 more
- Best Practice
- +3 more
-
Atlanta, GeorgiaEmory University Hospital/Winship Cancer Institute
Jan 3, 2023
Sarcopenic Male Colorectal Cancer Patients
Recruiting
- Colorectal Cancer
- +4 more
-
London, United KingdomLondon North West University Healthcare NHS Trust
May 4, 2022
Bariatric Surgery Candidate, Male Hypogonadism, Muscle Loss Trial in Esbjerg (Testosterone Undecanoate)
Recruiting
- Bariatric Surgery Candidate
- +2 more
- Testosterone Undecanoate
-
Esbjerg, DenmarkHospitalSWD
Oct 24, 2022
Arthroplasty, Replacement, Hip Trial in Des Plaines (Testosterone Therapy, No Testosterone Therapy)
Withdrawn
- Arthroplasty, Replacement, Hip
- Testosterone Therapy
- No Testosterone Therapy
-
Des Plaines, IllinoisAmerican Hip Institute Research Foundation
Feb 1, 2023
Boys With Pubertal Delay or Confirmed Hypogonadism
Recruiting
- Delayed Puberty
- Male Hypogonadism
- Testosterone Undecanoate
-
Buenos Aires, Distrito Federal, ArgentinaRodolfo Rey
Sep 12, 2022
Men With Low Testosterone Levels Trial in Culver City (Testosterone Enanthate, Placebo)
Completed
- Men With Low Testosterone Levels
- Testosterone Enanthate
- Placebo
-
Culver City, CaliforniaUrological Sciences Research Foundation
Apr 26, 2021
Gender Dysphoria, Voice Disorder Due to Transsexualism, Transgender Persons Trial in Ankara (Testosterone Hormon Therapy)
Recruiting
- Gender Dysphoria
- +3 more
- Testosterone Hormon Therapy
-
Ankara, TurkeyHacettepe University, Speech and Language Therapy
Mar 10, 2022
Hypogonadism, Male, Fatigue Syndrome, Chronic Trial in Boston, Seattle (Testosterone Undecanoate 750 MG/3 ML Intramuscular
Recruiting
- Hypogonadism, Male
- Fatigue Syndrome, Chronic
- Testosterone Undecanoate 750 MG/3 ML Intramuscular Solution [AVEED]
- placebo
-
Boston, Massachusetts
- +1 more
Aug 11, 2022
Testicular Cancer Trial in Groningen (Androgel (Testosterone gel), Placebo gel)
Recruiting
- Testicular Cancer
- Androgel (Testosterone gel)
- Placebo gel
-
Groningen, NetherlandsUniversity Medical Center Groningen
Jul 12, 2022
Hypogonadism Trial in United States (AndroGel 1.62%)
Completed
- Hypogonadism
- AndroGel 1.62%
-
Foley, Alabama
- +44 more
Jan 26, 2022
Opioid Use, Pain, Hypogonadism, Male Trial in Boston (Testosterone Undecanoate 250 MG/ML, Placebo)
Recruiting
- Opioid Use
- +2 more
- Testosterone Undecanoate 250 MG/ML
- Placebo
-
Boston, MassachusettsBrigham and Women's Hospital
Sep 16, 2022
Spinal Cord Injury, Spinal Cord Injuries, Trauma, Nervous System Trial in Tampa, Gainesville (Testosterone Enanthate,
Terminated
- Spinal Cord Injury
- +10 more
- Testosterone Enanthate
- +3 more
-
Tampa, Florida
- +1 more
Jul 28, 2022
Prostate Cancer, Castration-resistant Prostate Cancer, Metastatic Castration-resistant Prostate Cancer Trial in Baltimore
Recruiting
- Prostate Cancer
- +2 more
- Testosterone Undecanoate
- Enzalutamide
-
Baltimore, MarylandJohns Hopkins Hospital
May 6, 2022
Hypogonadism Trial in Odensen (Testosterone, )
Completed
- Hypogonadism
- Testosterone
- placebo
-
Odensen, DenmarkOdense University Hospital
Sep 15, 2020
Pain, Opioid Use, Androgen Deficiency Trial in Boston (Testosterone Cypionate, Placebo)
Recruiting
- Pain
- +2 more
- Testosterone Cypionate
- Placebo
-
Boston, MassachusettsBrigham and Women's Hospital
Apr 26, 2022
Metabolic Syndrome, Testicular Cancer, Leydig Cell Failure in Adult Trial in Copenhagen (Testosterone, Placebos)
Completed
- Metabolic Syndrome
- +2 more
- Testosterone
- Placebos
-
Copenhagen, DenmarkRigshospitalet
Mar 5, 2020
Castration-Resistant Prostate Carcinoma, Prostate Adenocarcinoma Trial in Seattle (Laboratory Biomarker Analysis, Olaparib,
Active, not recruiting
- Castration-Resistant Prostate Carcinoma
- Prostate Adenocarcinoma
- Laboratory Biomarker Analysis
- +5 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Oct 19, 2022
Long-term Lifestyle Change and Testosterone Replacement
Completed
- Hypogonadism
- +2 more
- Testosterone replacement
- lifestyle
-
Houston, TexasMichael E DeBakey VA Medical Center
Mar 8, 2021
Prostate Cancer, Recurrent Prostate Cancer, PET Positive Trial run by the National Cancer Institute (NCI) (Enzalutamide, M9241)
Not yet recruiting
- Prostate Cancer
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Oct 27, 2023
Androgen Metabolism, Metabolic Disease and Skeletal Muscle
Not yet recruiting
- Hypogonadism, Male
- +10 more
-
Dublin 9, IrelandBeaumont Hospital
Mar 16, 2023
Prostate Cancer Trial in Brazil (Testosterone Cypionate, Darolutamide)
Recruiting
- Prostate Cancer
- Testosterone Cypionate
- Darolutamide
-
Brasília, Distrito Federal, Brazil
- +4 more
Dec 22, 2022
Prostate Cancer Trial in Long Beach, West Los Angeles, Hines (stereotactic ablative radiotherapy, Pluvicto, topical
Not yet recruiting
- Prostate Cancer
- stereotactic ablative radiotherapy
- +2 more
-
Long Beach, California
- +2 more
Oct 13, 2023